A detailed history of Health Cor Management, L.P. transactions in Geron Corp stock. As of the latest transaction made, Health Cor Management, L.P. holds 500,000 shares of GERN stock, worth $2.29 Million. This represents 1.14% of its overall portfolio holdings.

Number of Shares
500,000
Previous 1,904,234 73.74%
Holding current value
$2.29 Million
Previous $4.46 Million 72.85%
% of portfolio
1.14%
Previous 0.56%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$2.03 - $2.42 $2.85 Million - $3.4 Million
-1,404,234 Reduced 73.74%
500,000 $1.21 Million
Q3 2022

Nov 14, 2022

BUY
$1.67 - $2.94 $1.51 Million - $2.66 Million
904,234 Added 90.42%
1,904,234 $4.46 Million
Q2 2022

Aug 15, 2022

BUY
$1.19 - $1.65 $119,000 - $165,000
100,000 Added 11.11%
1,000,000 $1.55 Million
Q1 2022

May 16, 2022

BUY
$0.99 - $1.6 $891,000 - $1.44 Million
900,000 New
900,000 $1.22 Million

Others Institutions Holding GERN

About GERON CORP


  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $1.73B
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track Health Cor Management, L.P. Portfolio

Follow Health Cor Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Health Cor Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Health Cor Management, L.P. with notifications on news.